Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-21,158
Closed -$2.77M 115
2023
Q3
$2.77M Buy
21,158
+11,860
+128% +$1.8M 1.41% 20
2023
Q2
$1.48M Buy
+9,298
New +$1.5M 0.71% 54
2020
Q2
Sell
-1,764
Closed -$305K 82
2020
Q1
$305K Buy
1,764
+1,432
+431% +$237K 0.53% 35
2019
Q4
$51K Buy
332
+1
+0.3% +$149 0.03% 138
2019
Q3
$50K Buy
331
+65
+24% +$10.3K 0.03% 117
2019
Q2
$41K Buy
266
+2
+0.8% +$306 0.02% 134
2019
Q1
$42K Buy
264
+2
+0.8% +$310 0.03% 125
2018
Q4
$40K Buy
262
+83
+46% +$12.9K 0.04% 107
2018
Q3
$27K Buy
179
+1
+0.6% +$142 0.02% 144
2018
Q2
$24K Buy
178
+2
+1% +$247 0.02% 143
2018
Q1
$23K Buy
176
+1
+0.6% +$134 0.02% 144
2017
Q4
$26K Buy
+175
New +$23.8K 0.02% 148

Other funds holding CLX

G&S Capital's CLX Position: Q4 2023 in Review

G&S Capital sold out of Clorox (CLX) in Q4 2023, closing a stake of 21,158 shares — an estimated $2.77M sold.

G&S Capital first reported a position in CLX in Q4 2017 and held it in 12 quarters. The position peaked at $2.77M in Q3 2023. 1,108 funds tracked by Wall St. Rank hold CLX as of Q4 2023.

  • G&S Capital reported no remaining Clorox position as of Q4 2023 after selling out during the quarter.
  • G&S Capital sold 21,158 Clorox shares in Q4 2023, an estimated $2.77M.
  • G&S Capital first reported a position in Clorox in Q4 2017 and held it in 12 quarters.
  • G&S Capital's Clorox position peaked at $2.77M in Q3 2023.
  • 1,108 funds tracked by Wall St. Rank held Clorox as of Q4 2023.

Based on G&S Capital's 13F filing for Q4 2023, filed 29 Jan 2024.